In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 24673-56-1, name is 3-Methylbenzofuran-2-carboxylic acid, introducing its new discovery. Recommanded Product: 3-Methylbenzofuran-2-carboxylic acid
Due to the interesting pharmacological activity observed for CI-988, a potent and selective CCK-B receptor antagonist, we have continued to study the SAR of this antagonist. This particular study examines the importance of the indole moiety for binding affinity. The synthesis and receptor binding affinity for analogs containing functionalized indole derivatives and replacing the indole with various heterocycles are reported.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 24673-56-1, and how the biochemistry of the body works.Recommanded Product: 3-Methylbenzofuran-2-carboxylic acid
Reference：
Benzofuran – Wikipedia,
Benzofuran | C8H2718O – PubChem